HC Sponsor LLC
Known title: 10% OwnerCIK: 0001833772
HC Sponsor LLC's purchase track record
How the stock did after each of HC Sponsor LLC's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since December 29, 2021
Stock higher 6 months later
0%
3 months: 25%
Median 6-month return
-64.2%
3 months: -30.6%
Beat the S&P 500
0%
median -50.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/3/2022 | HYPR | $88K | +5.6% | -51.3% | -7.3% |
| 1/21/2022 | HYPR | $405K | -13.3% | -66.9% | -9.9% |
| 1/10/2022 | HYPR | $166K | -47.9% | -76.2% | -17.5% |
| 12/29/2021 | HYPR | $700K | -50.9% | -61.5% | -20.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HYPR | ▼ Sell | Other | 5,534,000 | $0 | 12/16/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 21,947 | $88K | 2/3/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 78,053 | $292K | 1/26/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 25,000 | $113K | 1/21/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 8,410 | $55K | 1/12/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 2,913 | $20K | 1/11/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 13,677 | $92K | 1/10/2022 | View on chart |
| HYPR | ▲ Buy | Open Market | 100,000 | $700K | 12/29/2021 | View on chart |
| HYPR | ▼ Sell | Other | 5,534,000 | — | 12/22/2021 | View on chart |
| HYPR | ▲ Buy | Grant | 1,000,000 | — | 12/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Hyperfine Expands Portable Brain MRI Reach to Gulf Markets
Hyperfine has announced that its portable brain MRI system will now be available in key Gulf Cooperation Council countries, expanding its global footprint. The move follows the company’s recent rollout in other international markets and could increase adoption in the region’s hospitals. BTIG has reiterated a bullish stance, keeping its $2 price target unchanged. These developments highlight growing interest in Hyperfine’s technology.
Hyperfine Expands Portable Brain MRI Reach to Gulf Markets. Hyperfine has announced that its portable brain MRI system will now be available in key Gulf Cooperation Council countries, expanding its global footprint. The move follows the company’s recent rollout in other international markets and could increase adoption in the region’s hospitals. BTIG has reiterated a bullish stance, keeping its $2 price target unchanged. These developments highlight growing interest in Hyperfine’s technology.